|
Study subject serology results and indicators |
|||||||
| Subjects |
HCV PCR Copies per ml (Date of test) |
HepBsAb |
HepBsAg |
HepBcAb |
HIV Viral Load Copies per ml |
ALT U/L |
Liver Biopsy |
|
|
|||||||
| 1 |
10,800,000 (11/99) |
Neg |
Neg |
Pos |
633 (12/03) |
32 (12/03) |
Activity: Mild Stage 2 of 4 (08/00) |
| 34,500,000 IU (12/03) |
270,000 (01/03) |
||||||
|
|
|||||||
| 2 |
8,360,000 (09/99) |
Neg |
Neg |
Pos |
180,000 (10/03) |
16 (02/04) |
Not done due to bleeding diathesis |
| 96,000 (02/04) |
16 (10/03) |
||||||
|
|
|||||||
| 3 |
1,320,000 (10/03) |
Pos |
Neg |
Pos |
16,900 (02/04) |
110 (10/03) |
Grade 2/3 of 4 Stage 2/3 of 4 (11/03) |
| 182 (02/04) |
|||||||
|
|
|||||||
| 4 |
234,000 (12/02) |
Neg |
Neg |
Neg |
72,031 (12/02) |
37 (12/03) |
Grade 1 of 4 Stage 1 of 4 (11/03) |
| <50 (12/03) |
|||||||
|
|
|||||||
| 5 |
<600 |
Neg |
Neg |
Pos |
212,000 (10/03) |
41 (10/03) |
Not done |
| 104 (04/04) |
|||||||
|
HCV = hepatitis C virus; HepB = hepatitis B; s = surface; c = core; Ab = antibody; Ag = antigen; HIV = human immunodeficiency virus; ALT = alanine aminotransferase enzyme | |||||||
McMahon et al. Annals of Clinical Microbiology and Antimicrobials 2004 3:6 doi:10.1186/1476-0711-3-6 |
|||||||